News
SCNI
3.630
+0.28%
0.010
Scinai Immunotherapeutics to Hold Annual Shareholder Meeting
TipRanks · 2d ago
Weekly Report: what happened at SCNI last week (1007-1011)?
Weekly Report · 3d ago
Weekly Report: what happened at SCNI last week (0930-1004)?
Weekly Report · 10/07 09:37
Weekly Report: what happened at SCNI last week (0923-0927)?
Weekly Report · 09/30 09:35
Scinai Immunotherapeutics Licenses Global Rights
TipRanks · 09/26 17:17
Weekly Report: what happened at SCNI last week (0916-0920)?
Weekly Report · 09/23 09:35
Weekly Report: what happened at SCNI last week (0909-0913)?
Weekly Report · 09/16 09:32
Scinai Immunotherapeutics Restructures Debt, Eyes Growth
TipRanks · 09/09 11:51
Weekly Report: what happened at SCNI last week (0902-0906)?
Weekly Report · 09/09 09:35
Weekly Report: what happened at SCNI last week (0826-0830)?
Weekly Report · 09/02 09:36
Scinai Immunotherapeutics regains compliance with Nasdaq listing rule
Seeking Alpha · 08/29 11:15
Scinai Immunotherapeutics Back on Track with Nasdaq
TipRanks · 08/29 11:00
Weekly Report: what happened at SCNI last week (0819-0823)?
Weekly Report · 08/26 09:35
Scinai Immunotherapeutics Restructures Debt, Boosts Equity
TipRanks · 08/21 13:27
Scinai Secures $2M Investment Boost
TipRanks · 08/20 15:27
Weekly Report: what happened at SCNI last week (0812-0816)?
Weekly Report · 08/19 09:32
Scinai Immunotherapeutics reports H1 results
Seeking Alpha · 08/16 07:09
SCNI Stock Earnings: Scinai Immunotherapeutics Reported Results for Q2 2024
Investorplace · 08/15 17:52
Scinai Immunotherapeutics’ Strategic Growth and Drug Advancements
TipRanks · 08/15 11:57
Scinai Immunotherapeutics Restructures Debt
TipRanks · 08/13 21:49
More
Webull provides a variety of real-time SCNI stock news. You can receive the latest news about Scinai Immunotherapeutics Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About SCNI
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.